Doubts regarding IS variation, ISR failure & SEL/SPE Acceptance criteria [Regulatives / Guidelines]

posted by Ohlbe – France, 2021-05-12 12:51 (633 d 01:41 ago) – Posting: # 22344
Views: 1,195

Dear Thangairulappan S,

❝ 1) Why we are fixing IS variation range ±50% from the average IS response of accepted CCs &

❝ QCs.


Your choice. Guidelines say you should monitor IS response, but do not specify how. Bear in mind that ±x% limits are useful, but not sufficient. Tons of reasons why in this issue of Bioanalysis.

❝ (while using a deuterated IS why we not keeping ±15% or ±20% or some other range).


Actually, a number of labs are pleading that you could use wider acceptance limits if using a stable isotope labelled IS. The tighter the limits you set, the higher the number of samples you will have to re-analyse because of IS variation, with little or no added value.

❝ 2) If in one project ISR failure observed frequently/continuously means what will go to next

❝ actions and please give some examples with clarification for the reasons for those

❝ failures.


Some good reading material:

Aimin Tan, Sofi Gagnon-Carignan, Sylvain Lachance et al.
Beyond successful ISR: case-by-case investigations for unmatched reassay results when ISR passed
Bioanalysis (2011) 3(9), 1031–1038

Manish Yadav, Pranav S Shrivastav
Incurred sample reanalysis (ISR): a decisive tool in bioanalytical research
Bioanalysis (2011) 3(9), 1007–1024

Some interesting information also in this more recent paper. However I would not follow all of their proposals and recommendations, as they may not be accepted by regulators:

Morten Anders Kall, Marco Michi, Barry van der Strate et al.
Incurred sample reproducibility: 10 years of experiences: views and recommendations from the European Bioanalysis Forum
Bioanalysis (2018) 10(21), 1723–1732

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
22,478 posts in 4,708 threads, 1,603 registered users;
16 visitors (0 registered, 16 guests [including 11 identified bots]).
Forum time: 13:32 CET (Europe/Vienna)

If you don’t like something change it;
if you can’t change it, change the way you think about it.    Mary Engelbreit

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5